Blue Cap AG (XETRA:B7E.DE)
| Market Cap | 68.64M-25.0% |
| Revenue (ttm) | 136.46M-46.3% |
| Net Income | -18.99M+335.4% |
| EPS | -4.23+333.3% |
| Shares Out | 4.49M |
| PE Ratio | n/a |
| Forward PE | 20.22 |
| Dividend | €0.65(4.14%) |
| Ex-Dividend Date | Jun 24, 2026 |
| Volume | 25 |
| Open | 15.55 |
| Previous Close | 15.70 |
| Day's Range | 15.30 - 15.55 |
| 52-Week Range | 15.20 - 23.40 |
| Beta | 0.74 |
| Analysts | none |
| Price Target | 29.85(+95.10%) |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About B7E.DE
Blue Cap AG is a private equity firm based in Munich, Germany, specializing in investments in middle market, late-stage, mature, turnaround, recapitalization, buyout, special situations, restructuring, corporate carve-outs, and growth capital. It focuses on SMEs, particularly B2B companies in industrial goods and services across sectors such as adhesives & coatings, plastics, business services, and medical. The firm targets investments in Germany, Austria, and Switzerland, typically ranging from $5.65 million to $28.3 million in equity, with target sales between 20 million ($23.46 million) and 200 million ($234.65 million), and EBITDA up to $10 million. Blue Cap prefers majority stakes and aims for exits within three to seven years, investing from its balance sheet capital. Founded in 2006, the firm operates with a long-term, value-driven approach.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$B7E.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in B7E.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by B7E.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
B7E.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New B7E.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to B7E.DE from public contracts
Source: USAspending.gov
B7E.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from B7E.DE’s recent data — informational, not investment advice
